ACTRN12610000317099
Not yet recruiting
未知
Pilot trial invovling students at the University of Otago Wellington to determine the level of calcium phosphate mineral deposisted in dental plaque in vivo using a novel plaque mineralising toothpaste as a procedure to protect against dental caries.
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Dental caries
- Sponsor
- niversity of Otago
- Enrollment
- 50
- Status
- Not yet recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Radiation Therapy and Medical Students at the University of Otago Wellington
Exclusion Criteria
- •Requirement to treat for periodontal disease or other immediate dental treatment needed.
- •History of rheumatic heart disease/fever
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A pilot of a school-based program to foster effective bystander responses to racism and racial bullying among teachers and students in Australian schools.ACTRN12617000880347Australian National University1,200
Active, not recruiting
Phase 1
The influence of the medication Willfact on the blood loss of patient during the use of a heart-lung machineVon Willebrand Disease (VWD)MedDRA version: 19.1Level: PTClassification code 10069495Term: Acquired Von Willebrand's diseaseSystem Organ Class: 10005329 - Blood and lymphatic system disordersTherapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]EUCTR2016-000789-53-ATMedizinische Universität Innsbruck / Univ.-Klinik für Allgemeine und Chirurgische Intensivmedizin
Completed
Not Applicable
A pilot physical activity intervention for middle-aged Arab-Australian womePhysical inactivityPublic Health - Health promotion/educationACTRN12618001392257Western Sydney University22
Active, not recruiting
Not Applicable
A single center, open, pilot study to evaluate the pharmacokinetic profile of a new galenic formulation of an Ambroxol-Hydrochloride (Ambroxol-HCl) spray: Ambroxol CYATHUS” 50 mg/mL Oral Spray, administered in a single dose of 30 mg Ambroxol-HCl to healthy male volunteersMedDRA version: 8.1Level: LLTClassification code 10006440Term: Bronchial obstructionEUCTR2006-005291-41-ATCYATHUS Exquirere PharmaforschungsGmbH
Active, not recruiting
Phase 1
Pilot study to evaluate the efficacy and safety of mefloquine as prophylaxis in people exposed to the disease caused by the new SARS-CoV-2 coronavirus (COVID-19)COVID-19 infection is being spread around the world with more than 400.000 cases. The spred of the disease is being a world health problem.Therapeutic area: Diseases [C] - Virus Diseases [C02]EUCTR2020-001194-69-ESFélix Gutiérrez Rodero200